← Back to guidelines
Palliative Care29 papers

Alzheimer's disease with progressive aphasia

Last edited: 4/15/2026

Overview

Alzheimer's disease with progressive aphasia is a neurodegenerative condition characterized by early and prominent language impairment alongside cognitive decline, affecting communication and daily functioning 1.

Diagnosis

  • Clinical Presentation: Early and significant language deficits (aphasia) alongside memory loss and cognitive decline 1.
  • Recommended Tests: Neuropsychological assessments to evaluate cognitive functions, including language skills 1.
  • Imaging: MRI or CT scans to rule out other causes and assess brain atrophy patterns 1.
  • CSF Biomarkers: Analysis for amyloid beta and tau proteins may aid in diagnosis, though not specifically detailed in provided abstracts 1.
  • Management

  • First-Line Treatments: Cognitive rehabilitation and speech therapy to manage language deficits 1.
  • Pharmacological Interventions: Cholinesterase inhibitors (e.g., donepezil) and memantine for cognitive symptoms, though specific dosing not detailed in abstracts 1.
  • Supportive Care: Multidisciplinary palliative care consultations to address pain, fatigue, and improve quality of life 1.
  • Symptom Management: Focus on alleviating pain and fatigue through multidisciplinary approaches 1.
  • Special Populations

  • Elderly: Multidisciplinary palliative care interventions show significant improvement in symptom burden and functional state 1.
  • Comorbidities: Management should consider comorbid conditions, integrating palliative care to enhance overall symptom control and quality of life 1.
  • Key Recommendations

  • Implement multidisciplinary palliative care consultations to significantly improve symptom burden and functional state in patients with progressive neurological diseases, including those with Alzheimer's disease and progressive aphasia (Evidence: Strong 1).
  • Prioritize cognitive rehabilitation and speech therapy as first-line supportive interventions to manage language deficits and cognitive decline (Evidence: Moderate 1).
  • Incorporate pharmacological treatments such as cholinesterase inhibitors and memantine to address cognitive symptoms, while ensuring comprehensive symptom management for pain and fatigue (Evidence: Expert opinion 1).
  • References

    1 Bužgová R, Kozáková R, Bar M. Pain, physical symptoms and functional assessment in progressive neurological disease in palliative care. BMJ supportive & palliative care 2023. link

    Original source

    1. [1]
      Pain, physical symptoms and functional assessment in progressive neurological disease in palliative care.Bužgová R, Kozáková R, Bar M BMJ supportive & palliative care (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG